gemtuzumab ozogamicin
pfizer,ucb pharmaceuticals
['gemtuzumab', 'leusm', ' pom ', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)']
congress| #ash22 dr. katherine tarloc, of discusses targeted therapies in pediatric #aml, using case-based scenarios, highlighting agents that are currently available and in clinical development for this patient subset. #leusm #medicalcongress 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm